AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CEFTRIAXONE SODIUM +SULBACTAM SODIUM

28 registrations across 4 African markets— 27 active

Markets with CEFTRIAXONE SODIUM +SULBACTAM SODIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
INNO-CEFBACTUM 1.5G INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1000mg/500mg)🇬🇭GhanaactiveJan 2031
INNO-CEFBACTUM 1.5G INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1000mg/500mg)🇬🇭GhanaactiveJan 2031
INNO-CEFBACTUM 750MG INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 500mg/250mg)🇬🇭GhanaactiveJan 2031
INNO-CEFBACTUM 750MG INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 500mg/250mg)🇬🇭GhanaactiveJan 2031
G-CEFTRIA PLUS INJECTION (Each vial contains Ceftriaxone Sodium/ Sulbactam Sodium🇬🇭GhanaactiveDec 2030
G-CEFTRIA PLUS INJECTION (Each vial contains Ceftriaxone Sodium/ Sulbactam Sodium🇬🇭GhanaactiveDec 2030
BRITUM-S POWDER FOR INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1500mg)🇬🇭GhanaactiveNov 2030
BRITUM-S POWDER FOR INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1500mg)🇬🇭GhanaactiveNov 2030
CENBACTUM INJECTION🇬🇭GhanaactiveSept 2029
CENBACTUM INJECTION🇬🇭GhanaactiveSept 2029
GEBECEF PLUS INJECTION (Each vial contains Ceftriaxone Sodium/ Sulbactam Sodium 1g/ 500mg)🇬🇭GhanaactiveMar 2029
GEBECEF PLUS INJECTION (Each vial contains Ceftriaxone Sodium/ Sulbactam Sodium 1g/ 500mg)🇬🇭GhanaactiveMar 2029
SANTRIAX S-1000
Powder For Injection
🇰🇪KenyaBLISS GVS PHARMA LTDactiveSept 2028
FECTGO S INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1.5g)🇬🇭GhanaactiveOct 2027
FECTGO S INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1.5g)🇬🇭GhanaactiveOct 2027
CEZON-SB IG INJECTION🇬🇭GhanaactiveJun 2027
CEZON-SB IG INJECTION🇬🇭GhanaactiveJun 2027
TRIAF-S INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1.5 g)🇬🇭GhanaactiveApr 2027
TRIAF-S INJECTION (Each vial contains Ceftriaxone sodium/Sulbactam sodium 1.5 g)🇬🇭GhanaactiveApr 2027
CEFTRISONE_S_1.5G 1.5G INJECTION
INJECTION
🇲🇼MalawiexpiredMar 2025
CEFTRIAXONE SODIUM +SULBACTAM SODIUM
PARENTERAL ORDINARY VIALS
🇺🇬UgandaSAKAR HEALTHCARE LIMITEDactive
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive
CEFTRIAXONE SODIUM +SULBACTAM SODIUM
PARENTERAL ORDINARY VIALS
🇺🇬UgandaSAKAR HEALTHCARE LIMITEDactive
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaROYAL PHARMA 2011 LIMITEDactive
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaUNOSOURCE PHARMA LTD.active
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaROYAL PHARMA 2011 LIMITEDactive
CEFTRIAXONE SODIUM + SULBACTAM SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaUNOSOURCE PHARMA LTD.active

CEFTRIAXONE SODIUM +SULBACTAM SODIUM in Africa — Regulatory Overview

CEFTRIAXONE SODIUM +SULBACTAM SODIUM is registered across 4 African markets with 28 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 28 registrations, 27 (96%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.